PamGene
Latest round
- Series B
Last raised
- Jul 2003
Total raised
- $18M
Investors
- 4
About PamGene
PamGene operates in the biotechnology sector, focusing on multiplex kinase activity profiling. The company is headquartered in 's-Hertogenbosch, Netherlands.000 mn from SenterNovem.PamGene specializes in advanced biotechnology solutions that focus on multiplex kinase activity profiling technology. Their core offerings support physicians and scientists in optimizing patient treatment and understanding diseases. The flagship product measures cellular kinome activity in real time, aiding biomarker discovery, patient stratification, and therapy selection, especially for cancer applications. PamGene's technology is utilized across clinical, translational, and pre-clinical settings to analyze drug responses and optimize kinase inhibitors.PamGene generates revenue through its Contract Research Services and Diagnostic Assay Services (DAS), which are designed for partnerships with pharmaceutical and biotechnology firms. Clients engage PamGene for expertise in kinase profiling and biomarker discovery, utilizing the company’s advanced infrastructure and skilled personnel. The transaction model operates on a B2B basis, with clients commissioning specific assays or services tailored to their research. Revenue includes agreements for one-off projects and ongoing collaborations requiring repeated services over time.PamGene plans to expand its product offerings and enhance its market presence. The company is also focusing on market expansion in Europe, North America, and Asia, leveraging its existing partnerships and technological advancements.
Who invested in PamGene
4 investors across 2 rounds
See all investors in PamGene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PamGene
Who invested in PamGene?
PamGene has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PamGene raised?
PamGene has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PamGene last raise money?
PamGene's most recent round on record is a Series B, in Jul 2003.
What does PamGene do?
PamGene operates in the biotechnology sector, focusing on multiplex kinase activity profiling.
Where is PamGene headquartered?
PamGene is headquartered in 's-Hertogenbosch, Netherlands.
Which VCs invest in companies like PamGene?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at PamGene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like PamGene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.